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       Abstract 
Ischaemic Heart Disease is a condition that affects the supply of blood to the heart. The blood vessels are 
blocked due to the deposition of cholesterol plaques on their walls. This reduces the supply of oxygen  and  
nutrients  to the  heart musculature, which is essential for proper functioning of the heart. This may eventually 
result in a portion of the heart being suddenly deprived of its blood supply leading to the death of that area of 
heart tissue, resulting in heart attack.   
 In 1963 the Ministry of Railways carried out a survey with a view to ascertaining the number of deaths due to 
ischimic heart disease among railway populations in different parts of the country. The method employed was to 
obtain data from all the railway zones on a proforma based on W.H.O. classification 420, for arteriosclerotic, 
including coronary heart disease. 
 
The epidemiology studies have provided several key points of information related to the risk of developing IHD. 
First, several specific risk factors for IHD have been identified. Second, evidence that these factors are closely 
related to environmental and life-style changes implies that risk factors are potentially alterable. Third, these 
studies have stimulated further consideration and investigation of the basic mechanism of atherosclerosis. 
Angiographic studies have indicated a direct relationship between the risk factors and the severity of coronary 
disease.  
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Introduction 
 
Ischaemic Heart Disease is a condition that affects the supply of blood to the heart. The blood vessels are 
blocked due to the deposition of cholesterol plaques on their walls. This reduces the supply of oxygen  and  
nutrients  to the  heart musculature, which is essential for proper functioning of the heart. This may eventually 
result in a portion of the heart being suddenly deprived of its blood supply leading to the death of that area of 
heart tissue, resulting in heart attack.  
                As the heart is the pump that supplies oxygenated blood to the various vital organs, any defect in the 
heart immediately affects the supply of oxygen to the vital organs like the brain, kidneys etc. This leads to the 
death of tissue within these organs and their eventual failure or death. Ischaemic coronary artery disease is a 
condition  in which fatty deposits  accumulate in the cells lining the wall of the coronary arteries. These fatty 
deposits build up gradually and irregularly in the large branches of the two main coronary arteries which 
encircle the heart and are the main source of its blood supply. This process is called atherosclerosis which leads 
to  narrowing or hardening of the blood vessels supplying blood to the heart muscle. This  results in ischemia ( 
inability to provide adequate oxygen).    
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              Coronary artery disease is a leading cause of mortality and morbidity in most developed countries. 
Many studies have found gender-related differences in the presentations, prevalence, and clinical outcomes of 
CAD .CAD first presents itself in women approximately 10 years later than in men, most commonly after 
menopause .Compared to women, men present with ST-segment elevation myocardial infarction (MI) more 
often and have a higher prevalence of CAD adjusted for age However, younger women experience more adverse 
outcomes after MI and coronary artery bypass grafting surgery than men. A greater proportion of women than 
men with MI die of sudden cardiac arrest before reaching hospital .Previous reports have shown a 20% 
reduction in total mortality among patients randomized to exercise-based cardiac rehabilitation compared with 
controls receiving usual care. The outcome was however similar between men and women, although only 20% 
of all participants were women in many reports.  
 
 
 
1) Epidemiology 
 
 
United States:    
                     IHD is a major cause of death for men as young as 35 to 44 years of age, and the mortality rate of 
IHD rapidly increases with age. In fact, 35% of all deaths among men 55 to 64 years of age. are due to IHD. The 
differences in IHD rates between men and women are striking; the most recent data indicate that in the 35- to 
44-year-old age group, the male IHD mortality rate is 5.2 times higher than the female mortality rate. In the 65- 
to 74-year-old age group, however, the increased risk of IHD mortality is only 2.4 times higher for men than for 
women.  
 
Western European countries: 
                    Studies of migrants and people of similar ethnic backgrounds in different countries indicate that 
environmental factors are more influential on IHD incidence than genetic factors.3, 4 For example, the IHD 
mortality rate for native Japanese men is low in comparison with US men of similar age (95 vs 715 per 100,000, 
respectively).  
 
Hawaii and California: 
                     The most encouraging information derived from epidemiological studies to date has been the 
recent evidence that, between 1968 and 1978, the US-adjusted mortality from IHD decreased by 26.5%. 
Although researchers have no definitive proof, most of the accumulated evidence suggests strongly that this 
decline is due to changes in life styles and living habits.5-8 unfortunately, in most other countries, IHD rates are 
continuing toincrease or are showing significantly smaller declines. The long-term prospective epidemiological 
studies have been helpful in identifying the characteristics and personal life-style habits that relate to the 
probability of developing IHD.  
 
Epidemiological studies in India: 
                  In 1963 the Ministry of Railways carried out a survey with a view to ascertaining the number of 
deaths due to ischimic heart disease among railway populations in different parts of the country. The method 
employed was to obtain data from all the railway zones on a proforma based on W.H.O. classification 420, for 
arteriosclerotic, including coronary heart disease. This ascertainment of deaths was done by the different units, 
by a search of individual hospital records and electrocardiograms, and matching these with mortality returns of 
the units concerned. An independent means of checking the degree of ascertainment was the death certificate 
books in which disease as named in W.H.O. international statistical classification is mentioned.  
A final proof is provided by the data from two independent sources, namely the Employees' State Insurance 
Health Corporation (1957, 1958, and 1962) reported in part by Padmavati (1962), which pertains to non-railway 
industrial workers (Table1), and in an indirect way by the data of Singh and Prakash (1964), from a teaching 
hospital in the Punjab, north India, both of which showed similar geographical trends. These extra sources of 
information make it improbable that the geographical differences noted by us could be due to bias in our data. 
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1.1) Etiology 
 
Causes: 
               Numerous factors are responsible for the development of Ischaemic Heart Disease. The major risk 
factors are smoking, diabetes mellitus and cholesterol levels.  
 
• Those with Hypercholesterolaemia (elevated blood levels of cholesterol) have a much higher tendency 
to develop the disease. 
• There is also the theory that Hypertension is a risk factor in the development of Ischaemic Heart 
Disease, Genetic and hereditary factors may also be responsible for the disease.  
• Males are more prone to Ischaemic Heart Disease. However, in post-menopausal women, the risk is 
almost similar to that of men. Stress is also thought to be a risk factor, though there has been a great 
deal of debate on this factor of late. 
• The disease process occurs when an atheromatous plaque forms in the coronary vessels, leading to 
narrowing of the vessel walls and obstructing blood flow to the musculature of the heart.  
• Complete blockage results in deficient oxygenation and nutrient supply to the heart tissues, leading to 
damage, death and necrosis of the tissue, which is known as Myocardial Infarction (heart attack).  
 
Pathophysiology  
 
Pathophysiology is defined simply as "the physiology of disordered function. The basic underlying "disordered 
function" in patients with IHD is a reduced capacity for coronary artery blood (oxygen) supply to meet the 
myocardial oxygen demand.The individual with normal coronary arteries and normal left ventricular function 
has a linear relationship between myocardial oxygen demand and coronary blood supply. The determinants of 
myocardial oxygen demand relate to the work load on the myocardium and include heart rate, systemic systolic 
blood pressure, ventricular wall tension, and velocity of myocardial contractility. Clinically, the best indicator of 
myocardial oxygen demand is the product of the heart rate times the systolic blood pressure, referred to as the 
rate pressure product. 
The biggest drawback of this index of myocardial oxygen demand is that it does not allow for assessment of the 
effect of wall tension.. The determinants of coronary flow or supply include filling time or essentially the 
diastolic period, the driving pressure to fill the coronaries that is equal to the systemic diastolic pressure minus 
the left ventricular enddiastolic pressure, and the resistance of the coronary vascular bed. Despite decreases in 
diastolic filling time (35% to 40%) and decreases in systemic diastolic pressure during exercise, the normal 
coronary system is able to meet the myocardial oxygen demands as a result of reduced vascular resistance 
(dilatation) throughout the coronary system. 
 
 
 
2) CLINICAL MANIFESTATIONS 
 
• 2.1)  Chest Pain or Chest Discomfort : 
Few symptoms are more alarming than chest pain. In the minds of many people, chest pain equals heart pain. 
And while many other conditions can cause chest pain, cardiac disease is so common - and so dangerous that the 
symptom of chest pain should never be dismissed out of hand as being insignificant.  
 
• 2.2) Heart Palpitations : 
Palpitations, an unusual awareness of the heartbeat, are an extremely common symptom. Most people who 
complain of palpitations describe them either as "skips" in the heartbeat (that is, a pause, often followed by a 
particularly strong beat,) or as periods of rapid and/or irregular heart beats.   
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• 2.3) Lightheadedness or Dizziness : 
Episodes of lightheadedness or dizziness can have many causes, including anemia (low blood count) and other 
blood disorders, dehydration, viral illnesses, prolonged bed rest, diabetes, thyroid disease, gastrointestinal 
disturbances, liver disease, kidney disease, vascular disease, neurological disorders, dysautonomias, vasovagal 
episodes  
 
• 2.4) Syncope (Fainting/Loss of Consciousness) : 
Syncope is a sudden and temporary loss of consciousness, or fainting. It is a common symptom - most people 
pass out at least once in their lives - and often does not indicate a serious medical problem.  
 
• 2.5) Fatigue, Lethargy or Daytime Sleepiness : 
Fatigue, lethargy or somnolence (daytime sleepiness) is very common symptoms. Fatigue or lethargy can be 
thought of as an inability to continue functioning at one's normal levels.  
 
 
Diagnosis 
  Diagnosis of angina is a clinical diagnosis based on a characteristic complaint of chest discomfort or chest pain 
brought on by exertion and relieved by rest. Confirmation may be obtained by observing reversible ischemic 
changes on  ECG  during an attack or by giving a test dose of sublingual nitroglycerin that characteristically 
relieves the pain in 1 to 3 minutes.  
 
• Certain tests may help determine the severity of ischemia and the presence and extent of the coronary 
artery disease.  
• Diagnostic tests may include electrocardiogram (measures electrical activity of the heart), 
echocardiogram (measures sound waves), exercise-tolerance test, thallium stress test, blood studies to 
measure total fat, cholesterol and lipoproteins, X-rays of the chest and coronary angiogram. 
• Surgical therapy is indicated when medical treatment has failed to relieve symptoms or when the 
Angiogram shows significant disease in the blood vessels.  
• Coronary Angioplasty - dilating the blocked vessel by inflating a balloon inside the vessel and 
Coronary Artery Bypass Grafting (CABG) - replacing the blocked area of the vessel using a graft from 
the patient, may be done to relieve the blockage. 
• The indications for bypass surgery are increasingly becoming limited. This is due to the growing 
realization that except in selected cases, bypass surgery only helps to improve the quality of life and 
relieve symptoms. 
 
 
 
Prevention  
 Risk factors like a fatty diet, smoking; sedentary lifestyle and stress should be avoided, as they are the main 
areas of focus in prevention. Avoiding foods rich in saturated fats is vital to reduce lipid levels in the blood and 
to prevent arteriosclerosis. Adequate regular exercise is also essential.  
 
3) Primary Prevention  
The most successful programmes are those that, in a consistent and continuous way, combine various different 
measures, such as education, campaigns aimed at individual citizens, the promotion of healthier environments 
(e.g. smoke-free public spaces, healthy schools), financial incentives (e.g. taxes), legislative measures (e.g. food 
labeling, restrictions on marketing to children of foods/drinks that are high in fats, salt and sugar and low in 
essential nutrients), and initiatives addressing groups such as the food. 
 
3.2) Secondary prevention  
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  For high cholesterol and hypertension (high blood pressure), secondary prevention implies the detection of 
cases, either in the general population or in high-risk groups. The latter refers to groups for which a number of 
other risk factors have already been identified. 
 
   
Treatment : 
 
• Beta-blockers like Propranolol are also highly effective in relieving pain by reducing myocardial 
oxygen demand, mainly by decreasing the heart rate. 
• Calcium channel antagonists produce vasodilatation and relieve the symptoms by reducing the 
excitability and conductivity of cardiac muscle and by reducing blood pressure. 
• For patients with hypercholesterolaemia, drugs may be used to lower cholesterol levels. 
• Surgery to bypass coronary arteries (severe cases). End-stage coronary artery disease, even when no 
simple procedures will help, can still be cured with a heart transplant in rare cases. 
• With proper treatment, most patients will be able to lead normal and healthy lives. Treatment also 
involves advice regarding regular exercise, avoiding Good control of diabetes and hypertension.   
 
 
• Drug therapy with Nitrates, which dilate the diseased coronary arteries, administered sub-lingually are 
very effective in relieving the pain in a few minutes. 
• Drugs such as Isosorbide Dinitrate and Isosorbide Mononitrate belong to the category of Nitrates. 
These drugs are also used as a prophylactic to prevent the pain from occurring. 
 
Non-Pharmacological Treatment  
 
      1.Limit unhealthy fats and cholesterol : 
      2. Choose low-fat protein sources : 
      3. Eat more vegetables and fruits : 
      4. Yoga Treatment for Heart Diseases : 
 
Pharmacological Treatment  
 
Many cardiologists regard combined administration of conventional anti-anginal medications (including nitrates, 
Bblockers and calcium channel blockers) to be a more rational approach to the management of patients with 
angina than single-agent therapy. The rationale for this therapeutic strategy is based primarily on our knowledge 
of the pathophysiology of myocardial ischaemia and the mechanism of action of the various anti-ischaemic 
drugs. 
 
4) Classification Of Drug 
 
Some of the major types of commonly prescribed cardiovascular medications are summarized in this section. 
 
4.1)    ACE Inhibitors 
 
4.2)    Diuretics (Water Pills) 
 
4.3)    Vasodilators 
 
4.4)    Digitalis Preparations 
 
4.5)   Beta Blockers 
 
4.6)     Blood Thinners 
 
4.7)     Angiotensin II Receptor Blockers 
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4.8)     Calcium Channel Blockers 
 
Conclusion 
 
The epidemiology studies have provided several key points of information related to the risk of developing IHD. 
First, several specific risk factors for IHD have been identified. Second, evidence that these factors are closely 
related to environmental and life-style changes implies that risk factors are potentially alterable. Third, these 
studies have stimulated further consideration and investigation of the basic mechanism of atherosclerosis. 
Angiographic studies have indicated a direct relationship between the risk factors and the severity of coronary 
disease. Large prospective primary prevention trials have demonstrated that risk-factor reduction, specifically 
reduction in blood pressure and serum cholesterol decreases the chances of developing a future coronary event. 
Secondary prevention studies indicate that risk-factor reduction decreases the likelihood of coronary artery 
disease progression as measured by angiography and the chances of a repeat coronary event, including coronary 
death. These findings have important implications for physical therapists involved with either primary or 
secondary prevention clients. To design exercise programs aimed at risk-factor reduction, the therapist needs to 
be aware of the factors that influence myocardial oxygen supply and demand and be able to recognize an 
imbalance between supply and demand as manifested by symptoms, ECG abnormalities, abnormal blood 
pressure, and other clinical indicators of ischemia. 
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4.1)    ACE Inhibitors 
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Generic name Brand name(s) 
Captopril Capoten ® 
Enalapril Vasotec ® 
Ramipril Altace ® 
 
Side effects and special instructions :  
 
      Some people develop a persistent cough and kidney problems. It's also common for people to feel weak or 
dizzy when they first take these drugs, due to the lowering of blood pressure 
 
 
4.2)    Diuretics (Water Pills) 
Generic name Brand name(s) 
Hydrochlorothiazide HydroDIURIL ® 
Chlorothiazide Diuril ® 
 
Side effects and special instructions :  
            Some types of diuretics also remove potassium from the body.Diuretics can cause low blood pressure, 
kidney complications & excessive loss of potassium and fluid. 
 
4.3)    Vasodilators 
 
Generic name Brand name(s) 
isosorbide dinitrate Isordil ® 
Nesiritide Natrecor ® 
Hydralazine Apresoline ® 
Minoxidil Loniten® 
 
 
4.4)    Digitalis Preparations 
 
 
Generic name Brand name(s) 
Digoxin Lanoxin ® 
Digitoxin       - 
 
Side effects and special instructions: 
            For digoxin to be effective, patients must take the right amount. This means they will probably be given 
regular blood tests to see if their digoxin level is correct. 
 
4.5)   Beta Blockers 
 
Generic name Brand name(s) 
Carvedilol Coreg ® 
 
 
4.6)     Blood Thinners 
 
Generic name Brand name(s) 
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Warfarin Coumadin ® 
Heparin       - 
 
Side effects and special instructions :  
People taking blood thinners can have nosebleeds, bleeding in the gums and easy bruising. It's important to 
report bruises and bleeding to the doctor right away.  
 
 
 
4.7)     Angiotensin II Receptor Blockers 
 
Generic name Brand name(s) 
Losartan Cozaar ® 
Valsartan Diovan ® 
 
Side effects and special instructions : 
       Like other blood pressure-lowering medicines, angiotensin II receptor blockers may cause nausea, 
dizziness, headaches and low blood pressure.  
 
 
 
4.8)     Calcium Channel Blockers 
Generic name Brand name(s) 
Amlodipine Norvasc ® 
 
 
 
Table 1 Employees State Insurance Data 
 
 
 
 
 
  State No of new cases 
Per 1000 inssured person for 
1958-59* 
No of new cases 
Per 1000 inssured 
Person for 1961-62  
 Punjab(ps) 
 Dehli(ss) 
 Rajsthan(ss) 
 Uttar Pradesh(ss) 
 Maharashatra(ps) 
 Maharashtra(ss) 
 West Bengal(ps) 
 Bihar 
 Madras(ss) 
 Madras 
 West Bengal(ps) 
 Mysore(ss) 
 0-22 
 0-13 
 0-54 
 0-11 
 0-41 
 0-22 
 0-90 
 0-13 
 1-66 
 0-71 
 0-90 
 4-42 
 0-64 
 0-07 
 0-16 
 1-15 
 0-52 
 0-89 
 0-59 
 1-32 
 1-52 
 1-25 
 0-59 
 0-44 
     All India 
 
 0-63  0-62 
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